Juno Therapeutics, Inc., A Bristol-myers Squibb Company

This study is testing whether a new type of cell therapy, called CAR T-cells, is better and safer than current standard treatments for people with active systemic sclerosis (scleroderma) that affects the lungs. It will involve about 92 adults whose disease has not responded well …